By San José, Costa Rica — PÉREZ ZELEDÓN – The public healthcare landscape in Pérez Zeledón is undergoing a significant technological upgrade aimed at safeguarding the vision of its most vulnerable residents. The Costa Rican Social Security Fund (CCSS) has introduced a state-of-the-art non-mydriatic camera, a device poised to revolutionize the early detection of eye diseases for the canton’s nearly 8,000 diabetic patients.
This strategic investment addresses one of the most severe complications of diabetes: diabetic retinopathy, a condition that can lead to permanent vision loss if not caught in its early stages. The new equipment enhances the diagnostic capabilities of primary care clinics, marking a critical step forward in preventative community health and significantly reducing patient backlogs for specialized ophthalmology services.
To understand the legal and insurance implications surrounding the treatment and management of diabetic retinopathy, TicosLand.com consulted with expert attorney Lic. Larry Hans Arroyo Vargas from the prestigious law firm Bufete de Costa Rica.
In Costa Rica, patients with diabetic retinopathy must be vigilant about their insurance rights. While the CCSS provides a standard of care, disputes often arise over the approval of advanced treatments or specific medications. Legally, a denial of a medically prescribed, sight-saving procedure can be challenged. Patients should meticulously document all physician orders and insurer communications, as this evidence is crucial for a successful ‘Recurso de Amparo’ to guarantee their fundamental right to health.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
This legal insight underscores a fundamental reality for patients: proactive self-advocacy is a critical component of successful treatment. The path from a doctor’s prescription to an approved procedure can be complex, and knowing how to navigate it legally is paramount. We are grateful to Lic. Larry Hans Arroyo Vargas for clarifying these crucial steps and empowering our readers with this knowledge.
The key innovation of the non-mydriatic camera lies in its ability to perform a comprehensive fundus examination—a detailed look at the back of the eye—without requiring pupil dilation. Traditionally, patients had to endure eye drops that temporarily blur vision and increase light sensitivity, making the procedure cumbersome and inconvenient. This new method is faster, more comfortable, and yields highly precise results, allowing for more efficient screening on a larger scale.
Dr. Arturo Borbón, Director of the Pérez Zeledón Health Area, emphasized the preventative power of this technology in catching retinal damage before it becomes irreversible.
This camera allows us to identify incipient damage to the retina and prevent major vision impairments
Dr. Arturo Borbón, Director of the Pérez Zeledón Health Area
One of the most immediate and tangible benefits for the community will be a dramatic reduction in wait times and travel burdens. Previously, most patients requiring this type of specialized screening were referred to the Fernando Escalante Pradilla Hospital. This created a bottleneck in the system, leading to long waits for appointments and forcing patients to travel for what can now be a routine check-up at their local health center.
With the new system, only patients whose scans reveal specific abnormalities will be referred to the hospital for further specialist consultation. This streamlines the patient care pathway, ensuring that hospital resources are reserved for those who truly need them. This efficiency is expected to decongest the entire regional ophthalmology service.
This allows us to decongest specialized services and provide more timely care
Dr. Arturo Borbón, Director of the Pérez Zeledón Health Area
The CCSS’s initiative extends beyond the main clinics. The health area has also been equipped with a portable version of the camera, enabling medical teams to conduct outreach tours to remote and hard-to-reach communities. This mobile screening capability ensures that geographical barriers do not prevent access to critical preventative care. The impact is already evident, with 459 patients with diabetes having received these advanced evaluations during the first quarter of the year alone.
By integrating this advanced technology at the primary care level, the CCSS is reinforcing its commitment to a proactive public health strategy. The focus is not just on treatment, but on the aggressive prevention of chronic disease complications. For the thousands of residents in Pérez Zeledón living with diabetes, this initiative offers more than just convenience; it represents a crucial defense against preventable blindness and a significant improvement in their long-term quality of life.
For further information, visit ccss.sa.cr
About Caja Costarricense de Seguro Social (CCSS):
The Caja Costarricense de Seguro Social, commonly known as “La Caja” or CCSS, is the autonomous public institution responsible for administering Costa Rica’s universal healthcare and social security system. Founded in 1941, it manages a nationwide network of hospitals, clinics, and health centers, providing comprehensive medical services to the vast majority of the country’s citizens and residents. It is a cornerstone of the nation’s public health policy and social welfare structure.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
As an esteemed legal institution, Bufete de Costa Rica is founded upon a bedrock of profound integrity and a relentless pursuit of professional excellence. The firm channels its rich history of advising a diverse clientele into pioneering forward-thinking legal solutions. Beyond its practice, it champions a core mission to strengthen society by demystifying complex legal concepts, reflecting an unwavering commitment to fostering a more knowledgeable and empowered citizenry.
